Citation: Han Sheng, Lei Yuan, Pannecouque Christophe, De Clercq Erik, Zhuang Chunlin, Chen Fener. Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors[J]. Chinese Chemical Letters, ;2020, 31(3): 764-768. doi: 10.1016/j.cclet.2019.11.020 shu

Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors

Han Sheng ^a,b,1 ,
Lei Yuan ^c,1 ,
Pannecouque Christophe ^e ,
De Clercq Erik ^e ,
Zhuang Chunlin ^a,b,*, ,
Chen Fener ^a,b,c,d,*,

a.
Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China
b.
Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China
c.
Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
d.
Institute of Pharmaceutical Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China
e.
Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium

zclnathan@163.com

rfchen@fudan.edu.cn

Received Date: 9 October 2019
Revised Date: 11 November 2019
Accepted Date: 11 November 2019
Available Online: 1 March 2020

Figures(4)

Two series of sulfur-containing diarylbenzopyrimidines are designed by the fragment combination of a thioacetamide with our previous disclosed DABP 3 and further oxidation. The best compound 6e with a sulfonyl scaffold displayed EC₅₀ values of 0.0356 μmol/L against WT and 0.0228 μmol/L against HIV K103N mutant strain. More pronounced, it had a lower cytotoxicity (CC₅₀=99.6 μmol/L), higher selectivity index (SI_WT=2799, SI_K103N=4375) and better calculated logarithm of the octanol-water partition coefficient (cLogP) than the lead compound 3. Molecular docking and dynamics provided the binding modes of these compounds with reverse transcriptase, explaining their activity. Collectively, the new compounds could be candidates for anti-HIV drug discovery.
- HIV-1,
- NNRTIs,
- DAPY,
- Sulfur-containing DABPs,
- FBDD
1. [1]
  R.C. Gallo, L. Montagnier, N. Engl. J. Med. 349(2003) 2283-2285. doi: 10.1056/NEJMp038194
2. [2]
  WHO website, HIV/AIDS Fact Sheet (Last Accessed August 26, 2019), https://www.who.int/hiv/data/en/.
3. [3]
  E. De Clercq, J. Med. Chem. 62(2019) 7322-7339. doi: 10.1021/acs.jmedchem.9b00175
4. [4]
  B. Huang, W. Chen, T. Zhao, et al., J. Med. Chem. 62(2019) 2083-2098. doi: 10.1021/acs.jmedchem.8b01729
5. [5]
  D. Kang, H. Zhang, Z. Wang, et al., J. Med. Chem. 62(2019) 1484-1501. doi: 10.1021/acs.jmedchem.8b01656
6. [6]
  Z. Zhou, T. Liu, D. Kang, et al., Org. Biomol. Chem. 16(2018) 1014-1028. doi: 10.1039/C7OB02828H
7. [7]
  V. Namasivayam, M. Vanangamudi, V.G. Kramer, et al., J. Med. Chem. 62(2019) 4851-4883. doi: 10.1021/acs.jmedchem.8b00843
8. [8]
  Y. Hsiou, J. Ding, K. Das, et al., J. Mol. Biol. 309(2001) 437-445. doi: 10.1006/jmbi.2001.4648
9. [9]
  K. Das, E. Arnold, Curr. Opin. Virol. 3(2013) 111-118. doi: 10.1016/j.coviro.2013.03.012
10. [10]
  K. Das, E. Arnold, Curr. Opin. Virol. 3(2013) 119-128. doi: 10.1016/j.coviro.2013.03.014
11. [11]
  C.J. Cohen, J. Andrade-Villanueva, B. Clotet, et al., Lancet 378(2011) 229-237. doi: 10.1016/S0140-6736(11)60983-5
12. [12]
  J. Lindberg, S. Sigurdsson, S. Lowgren, et al., Eur. J. Biochem. 269(2002) 1670-1677. doi: 10.1046/j.1432-1327.2002.02811.x
13. [13]
  J. Ren, J. Milton, K.L. Weaver, et al., Structure 8(2000) 1089-1094. doi: 10.1016/S0969-2126(00)00513-X
14. [14]
  Y. Yang, D. Kang, L.A. Nguyen, et al., Steitz, Elife 7(2018)E36340.
15. [15]
  M.B.Nawrozkij, M.Forgione, A.S.Yablokov, et al., J.Med.Chem.62(2019)604-621. doi: 10.1021/acs.jmedchem.8b01238
16. [16]
  M.T. Lai, V. Munshi, M. Lu, et al., Viruses 8(2016) E263. doi: 10.3390/v8100263
17. [17]
  M. Udier-Blagovi c, J. Tirado-Rives, W.L. Jorgensen, et al., J. Am. Chem. Soc. 125(2003) 6016-6017. doi: 10.1021/ja034308c
18. [18]
  K. Das, A.D. Clark Jr., P.J. Lewi, et al., J. Med. Chem. 47(2004) 2550-2560. doi: 10.1021/jm030558s
19. [19]
  J. Adams, N. Patel, N. Mankaryous, M. Tadros, C.D. Miller, Ann. Pharmacother. 44(2010) 157-165. doi: 10.1345/aph.1M359
20. [20]
  A.Blas-Garcia, J.V.Esplugues, N.Apostolova, Curr.Med.Chem.18(2011)2186-2195. doi: 10.2174/092986711795656180
21. [21]
  European Medicines Agency web site, Pifeltro: European Public Assessment Report-Medicine Overview, 2019. (Last Accessed August 26, 2019) https://www.ema.europa.eu/en/medicines/human/EPAR/pifeltro
22. [22]
  X. Li, B. Chen, L. Lan, et al., Chin. Chem. Lett. 29(2018) 1637-1640. doi: 10.1016/j.cclet.2018.06.003
23. [23]
  Y. Guo, L. Fu, X. Fan, X. Shi, Chin. Chem. Lett. 29(2018) 1167-1170. doi: 10.1016/j.cclet.2018.03.024
24. [24]
  W.H. Zhou, X.G. Xu, J. Li, et al., Chin. Chem. Lett. 28(2017) 422-425. doi: 10.1016/j.cclet.2016.09.001
25. [25]
  S. Han, Y. Sang, Y. Wu, et al., ACS Infect. Dis. (2019), doi: http://dx.doi.org/10.1021/acsinfecdis.9b00229.
26. [26]
  M.D. Shultz, J. Med. Chem. 62(2019) 1701-1714. doi: 10.1021/acs.jmedchem.8b00686
27. [27]
  E.A. Ilardi, E. Vitaku, J.T. Njardarson, J. Med. Chem. 57(2014) 2832-2842. doi: 10.1021/jm401375q
28. [28]
  Z.Y. Wan, J. Yao, T.Q. Mao, et al., Eur. J. Med. Chem. 102(2015) 215-222. doi: 10.1016/j.ejmech.2015.08.007
29. [29]
  Z.Y. Wan, Y. Tao, Y.F. Wang, et al., Bioorg. Med. Chem. 23(2015) 4248-4255. doi: 10.1016/j.bmc.2015.06.048
1. [1]
  Guo Ye , Fu Lili , Fan Xiaowen , Shi Xuanling . Stapled SC34EK fusion inhibitors with high potency against HIV-1 and improved protease resistance. Chinese Chemical Letters, 2018, 29(7): 1167-1170. doi: 10.1016/j.cclet.2018.03.024
2. [2]
  Zhao Jiaoyan , Jiang Xuefeng . The application of sulfur-containing peptides in drug discovery. Chinese Chemical Letters, 2018, 29(7): 1079-1087. doi: 10.1016/j.cclet.2018.05.026
3. [3]
  Guo Ye , Fu Lili , Fan Xiaowen , Shi Xuanling . Synthesis and Anti-HIV-1 Activity of Stapled HIV-1 Fusion Inhibitors. Chinese Journal of Organic Chemistry, 2018, 38(5): 1267-1270. doi: 10.6023/cjoc201710033
4. [4]
  Yan Zhao , Jie Ding , Xue-Bin Huang . Synthesis and self-assembly of phthalocyanines bearing sulfur-containing substituents. Chinese Chemical Letters, 2014, 25(1): 46-50.
5. [5]
  Xiao Ling ZHANG , Jing Song YOU , Xing Shu LI , Ru Gang XIE . The Synthesis of New Sulfur-containing Chiral Macrocyclic Ligand. Chinese Chemical Letters, 1997, 8(10): 853-854.
6. [6]
  Ping Zhen WANG , Yan Xing JIA , Yong Qiang TU , Bin WU . Synthetic Studies of an Analogue of HIV-1 Protease Inhibitors of Didemnaketals:Construction of the C1-C8 Intermediate. Chinese Chemical Letters, 1999, 10(9): 749-750.
7. [7]
  HU Jian-Ping , KE Guo-Tao , CHANG Shan , CHEN Wei-Zu , WANG Cun-Xin . Conformational Change of HIV-1 Viral DNA after Binding with Integrase. Acta Physico-Chimica Sinica, 2008, 24(10): 1803-1810. doi: 10.3866/PKU.WHXB20081012
8. [8]
  SHI Ya-Wei , LIU Zhen-Ming , JIN Hong-Wei , ZHANG Liang-Ren , ZHANG Li-He . Quantitative Structure-Activity Relationships of HIV-1 Integrase Inhibitors of DKAs. Acta Physico-Chimica Sinica, 2007, 23(09): 1393-1398. doi: 10.3866/PKU.WHXB20070916
9. [9]
  Tao Liu , Ai Xiu Li , You Pan Miao , Ke Zhu Wu , Yi Ma . Screening of new non-nucleoside reverse transcriptase inhibitors of HIV-1 based on traditional Chinese medicines database. Chinese Chemical Letters, 2009, 20(11): 1386-1388. doi: 10.1016/j.cclet.2009.04.007
10. [10]
  Hui Hui Li , Gu Yuan . Investigation of formation of dimeric G-quadruplex of HIV-1 integrase inhibitor by nuclear magnetic resonance. Chinese Chemical Letters, 2008, 19(9): 1108-1110. doi: 10.1016/j.cclet.2008.06.010
11. [11]
  Jing Su , Yao Liu , Zhi Bing Zheng , Jun Hai Xiao , Hong Lu , Wu Zhong , Li Li Wang , Shi Bo Jiang , Song Li . Synthesis of aromatic-linked polyamine macrocyclic derivatives as HIV-1 entry inhibitors. Chinese Chemical Letters, 2007, 18(10): 1166-1168. doi: 10.1016/j.cclet.2007.08.021
12. [12]
  Jun Mei WANG , Ting Jun HOU , You Yong Li , Xiao Jie XU . The QSAR Research of Pyrrolobenzothiazepinones and Pyrrolobenzo-xazepinones-Novel and Specific Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Chinese Chemical Letters, 1997, 8(10): 889-892.
13. [13]
  Xiao Hui LIU , Lin WANG , Bao He GUAN , Man KONG , Xing Quan ZHANG , Pei Zhen TAo , Hong Shan CHEN . SYNTHESIS AND ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1(HIV-1) ACTIVITY OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (1)AND ITS REGIOISOMER 3-(2-PHOSPHONYLMETHOXYETHYL)ADENINE(2). Chinese Chemical Letters, 1995, 6(8): 669-672.
14. [14]
  Xin CHEN , Lin WANG , Zhi Zhong ZHAO , Xing Quan ZHANG , Xiang Hong CHEN , Hong Shan CHEN . Synthesis of Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors-1-(3-Phthalimido-2-oxobutyl)-4-Substituted-phenylpiperazines. Chinese Chemical Letters, 2000, 11(7): 571-572.
15. [15]
  Shu Xian LIU , Bai Tao LI , Li WANG , Yan Yong LIU , En Bo WANG , Yi ZENG , Ze Lin LI . SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF HETEROPOLY COMPLEXES OF TUNGSTOTITANOPHOSPHATES CONTAINING RARE EARTH ELEMENTS. Chinese Chemical Letters, 1996, 7(8): 777-778.
16. [16]
  LIU Chun-li , LI Chun-hua , CHEN Wei-zu , WANG Cun-xin . Study on Interaction between HIV-1 Integrase and Its Dicaffeoyl Inhibitors through Molecular Modeling Approach. Acta Physico-Chimica Sinica, 2005, 21(11): 1229-1234. doi: 10.3866/PKU.WHXB20051107
17. [17]
  Liu Donglin , Liu Yingxiang , Li Geng , Ma Yuzhuo , Zeng Qiaolin . Study on 3D-QSAR, Molecular Docking and Molecular Dynamics of HIV-1 Integrase Chain Transfer Inhibitors. Chemistry, 2019, 82(7): 642-648.
18. [18]
  Yan Song ZHENG , Zhi Tang RUANG . Synthesis of Sulfur Containing Calixcrown and Its Complexing Properties. Chinese Chemical Letters, 1997, 8(8): 685-688.
19. [19]
  Jian Yang , Ju-Rong Li , Jing-Xiang Yang , Long-Long Li , Wen-Jie Ouyang , Shu-Wen Wu , Fang Zhang . Synthesis and anti-HIV-1 activity of the conjugates of gossypol with oligopeptides and D-glucosamine. Chinese Chemical Letters, 2014, 25(7): 1052-1056. doi: 10.1016/j.cclet.2014.05.030
20. [20]
  Xin Yong Liu , Ren Zhang Yan , Nian Gen Chen , Wen Fang Xu . Regioselective synthesis and anti-HIV activity of the novel 2-and 4-substituted pyrazolo[4,5-e] [1,2,4]thiadiazines. Chinese Chemical Letters, 2007, 18(2): 137-140. doi: 10.1016/j.cclet.2006.12.006

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(91)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142